| Bioactivity | GNF6702 is a selective inhibitor of the kinetoplastid proteasome. GNF6702 clears parasites in murine models of leishmaniasis, Chagas disease, and human African trypanosomiasis[1]. |
| Name | GNF6702 |
| CAS | 1799329-72-8 |
| Formula | C22H16FN7O2 |
| Molar Mass | 429.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nagle A, et al. Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases. J Med Chem. 2020;63(19):10773-10781. |
GNF6702
CAS: 1799329-72-8 F: C22H16FN7O2 W: 429.41
GNF6702 is a selective inhibitor of the kinetoplastid proteasome. GNF6702 clears parasites in murine models of leishmani
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.